BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 16936926)

  • 1. Reducing implant-related infections: active release strategies.
    Hetrick EM; Schoenfisch MH
    Chem Soc Rev; 2006 Sep; 35(9):780-9. PubMed ID: 16936926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silver.
    Monteiro DR; Gorup LF; Takamiya AS; Ruvollo-Filho AC; de Camargo ER; Barbosa DB
    Int J Antimicrob Agents; 2009 Aug; 34(2):103-10. PubMed ID: 19339161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antibacterials on biofilms.
    Aslam S
    Am J Infect Control; 2008 Dec; 36(10):S175.e9-11. PubMed ID: 19084156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of bacterial adhesion on medical devices.
    Rodrigues LR
    Adv Exp Med Biol; 2011; 715():351-67. PubMed ID: 21557075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staphylococci and implant surfaces: a review.
    Harris LG; Richards RG
    Injury; 2006 May; 37 Suppl 2():S3-14. PubMed ID: 16651069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implant infections: a haven for opportunistic bacteria.
    Schierholz JM; Beuth J
    J Hosp Infect; 2001 Oct; 49(2):87-93. PubMed ID: 11567552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition of bacterial adhesion and prevention of biofilm formation: Use of organic self-assembled monolayers on inorganic surfaces].
    Guerrero G; Amalric J; Mutin PH; Sotto A; Lavigne JP
    Pathol Biol (Paris); 2009 Feb; 57(1):36-43. PubMed ID: 18824310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Device-associated infections: a macroproblem that starts with microadherence.
    Darouiche RO
    Clin Infect Dis; 2001 Nov; 33(9):1567-72. PubMed ID: 11577378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Periprosthetic Infection Strategies: From Implant Surface Topographical Engineering to Smart Drug-Releasing Coatings.
    Ghimire A; Song J
    ACS Appl Mater Interfaces; 2021 May; 13(18):20921-20937. PubMed ID: 33914499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The challenge of treating biofilm-associated bacterial infections.
    del Pozo JL; Patel R
    Clin Pharmacol Ther; 2007 Aug; 82(2):204-9. PubMed ID: 17538551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staphylococcus epidermidis device-related infections: pathogenesis and clinical management.
    McCann MT; Gilmore BF; Gorman SP
    J Pharm Pharmacol; 2008 Dec; 60(12):1551-71. PubMed ID: 19000360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic-eluting medical devices for various applications.
    Zilberman M; Elsner JJ
    J Control Release; 2008 Sep; 130(3):202-15. PubMed ID: 18687500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New antibiotic agents and approaches to treat biofilm-associated infections.
    Lynch AS; Abbanat D
    Expert Opin Ther Pat; 2010 Oct; 20(10):1373-87. PubMed ID: 20636186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial adherence and biofilm formation on medical implants: a review.
    Veerachamy S; Yarlagadda T; Manivasagam G; Yarlagadda PK
    Proc Inst Mech Eng H; 2014 Oct; 228(10):1083-99. PubMed ID: 25406229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection.
    Cirioni O; Giacometti A; Ghiselli R; Kamysz W; Silvestri C; Orlando F; Mocchegiani F; Vittoria AD; Kamysz E; Saba V; Scalise G
    Peptides; 2007 Jun; 28(6):1299-303. PubMed ID: 17537542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biocompatibility and biofilm resistance of implant coatings based on hydrophilic polymer brushes conjugated with antimicrobial peptides.
    Gao G; Lange D; Hilpert K; Kindrachuk J; Zou Y; Cheng JT; Kazemzadeh-Narbat M; Yu K; Wang R; Straus SK; Brooks DE; Chew BH; Hancock RE; Kizhakkedathu JN
    Biomaterials; 2011 Jun; 32(16):3899-909. PubMed ID: 21377727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo model of human pathogen infection and demonstration of efficacy by an antimicrobial pouch for pacing devices.
    Hansen LK; Brown M; Johnson D; Palme Ii DF; Love C; Darouiche R
    Pacing Clin Electrophysiol; 2009 Jul; 32(7):898-907. PubMed ID: 19572866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of implant porosity on the development of infection.
    Kiechel SF; Rodeheaver GT; Klawitter JJ; Edgerton MT; Edlich RF
    Surg Gynecol Obstet; 1977 Jan; 144(1):58-62. PubMed ID: 831295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Device-related nosocomial infection. Reducing infection with antimicrobial materials and coatings.
    Milder F
    Med Device Technol; 1999 Mar; 10(2):34-9. PubMed ID: 10387613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.